News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
249,557 Results
Type
Article (12145)
Company Profile (87)
Press Release (237325)
Multimedia
Podcasts (68)
Webinars (12)
Section
Business (85159)
Career Advice (1249)
Deals (14283)
Drug Delivery (65)
Drug Development (16724)
Employer Resources (136)
FDA (4226)
Job Trends (6451)
News (123149)
Policy (9871)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (4)
2024 BioMidwest Digital (3)
2024 Bio NC Digital (2)
2024 Biotech Bay Standard (8)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (1)
2024 Genetown Standard (4)
2024 Lone Star Bio Digital (3)
2024 Pharm Country Digital (2)
2025 Lone Star Bio Digital (2)
2026 BioCapital Elite (1)
Academia (815)
Accelerated approval (2)
Adcomms (3)
Allergies (13)
Alliances (21826)
ALS (29)
Alzheimer's disease (330)
Antibody-drug conjugate (ADC) (51)
Approvals (4236)
Artificial intelligence (170)
Autoimmune disease (8)
Automation (12)
Bankruptcy (82)
Best Places to Work (4967)
BIOSECURE Act (19)
Biosimilars (35)
Biotechnology (67)
Bladder cancer (21)
Brain cancer (8)
Breast cancer (81)
Cancer (675)
Cardiovascular disease (34)
Career advice (1053)
Career pathing (25)
CAR-T (54)
Cell therapy (180)
Cervical cancer (10)
Clinical research (13531)
Collaboration (395)
Compensation (108)
Complete response letters (2)
COVID-19 (724)
CRISPR (20)
C-suite (170)
Cystic fibrosis (36)
Data (579)
Decentralized trials (1)
Denatured (31)
Depression (14)
Diabetes (64)
Diagnostics (2559)
Digital health (10)
Diversity (6)
Diversity, equity & inclusion (30)
Drug discovery (49)
Drug pricing (69)
Drug shortages (13)
Duchenne muscular dystrophy (21)
Earnings (23751)
Editorial (29)
Employer branding (17)
Employer resources (114)
Events (34389)
Executive appointments (535)
FDA (4598)
Featured Employer (24)
Friedreich's ataxia (3)
Frontotemporal dementia (2)
Funding (330)
Gene editing (44)
Generative AI (17)
Gene therapy (116)
GLP-1 (276)
Government (1500)
Guidances (30)
Healthcare (6517)
Huntington's disease (9)
IgA nephropathy (7)
Immunology and inflammation (33)
Indications (11)
Infectious disease (771)
Inflammatory bowel disease (42)
Inflation Reduction Act (9)
Influenza (19)
Intellectual property (39)
Interviews (198)
IPO (5413)
IRA (38)
Job creations (1618)
Job search strategy (909)
Kidney cancer (8)
Labor market (33)
Layoffs (145)
Leadership (17)
Legal (2177)
Liver cancer (22)
Lung cancer (101)
Lymphoma (47)
Machine learning (5)
Management (42)
Manufacturing (194)
MASH (19)
Medical device (4873)
Medtech (4877)
Mergers & acquisitions (9209)
Metabolic disorders (199)
Multiple sclerosis (27)
NASH (1)
Neurodegenerative disease (31)
Neuropsychiatric disorders (10)
Neuroscience (518)
NextGen: Class of 2025 (2920)
Non-profit (1285)
Northern California (1011)
Now hiring (20)
Obesity (107)
Opinion (192)
Ovarian cancer (27)
Pain (23)
Pancreatic cancer (19)
Parkinson's disease (39)
Partnered (14)
Patents (93)
Patient recruitment (23)
Peanut (4)
People (34307)
Pharmaceutical (16)
Pharmacy benefit managers (15)
Phase I (4295)
Phase II (6019)
Phase III (4790)
Pipeline (417)
Policy (119)
Postmarket research (450)
Preclinical (1944)
Press Release (55)
Prostate cancer (25)
Psychedelics (10)
Radiopharmaceuticals (122)
Rare diseases (127)
Real estate (3133)
Recruiting (58)
Regulatory (6838)
Reports (28)
Research institute (889)
Resumes & cover letters (202)
Rett syndrome (1)
RNA editing (3)
RSV (9)
Schizophrenia (31)
Series A (72)
Series B (34)
Service/supplier (6)
Sickle cell disease (11)
Southern California (883)
Special edition (9)
Spinal muscular atrophy (35)
Sponsored (17)
Startups (1791)
State (1)
Stomach cancer (3)
Supply chain (41)
Tariffs (36)
The Weekly (36)
United States (8058)
Vaccines (148)
Venture capitalists (26)
Weight loss (80)
Women's health (17)
Worklife (14)
Date
Today (56)
Last 7 days (302)
Last 30 days (991)
Last 365 days (11936)
2025 (4001)
2024 (12732)
2023 (14785)
2022 (21939)
2021 (22528)
2020 (21053)
2019 (19828)
2018 (14779)
2017 (12306)
2016 (11563)
2015 (13045)
2014 (9491)
2013 (8288)
2012 (9691)
2011 (9877)
2010 (8260)
Location
Africa (378)
Alabama (13)
Alaska (4)
Arizona (90)
Arkansas (5)
Asia (16729)
Australia (2297)
California (2289)
Canada (760)
China (222)
Colorado (96)
Connecticut (99)
Delaware (44)
Europe (32825)
Florida (317)
Georgia (58)
Idaho (25)
Illinois (231)
India (14)
Indiana (131)
Iowa (7)
Japan (61)
Kansas (40)
Kentucky (8)
Louisiana (7)
Maine (12)
Maryland (233)
Massachusetts (1386)
Michigan (115)
Minnesota (122)
Mississippi (2)
Missouri (25)
Montana (6)
Nebraska (15)
Nevada (18)
New Hampshire (40)
New Jersey (617)
New Mexico (10)
New York (676)
North Carolina (425)
North Dakota (6)
Northern California (1011)
Ohio (105)
Oklahoma (10)
Oregon (12)
Pennsylvania (381)
Puerto Rico (4)
Rhode Island (13)
South America (545)
South Carolina (15)
Southern California (883)
Tennessee (29)
Texas (296)
Utah (62)
Virginia (36)
Washington D.C. (21)
Washington State (131)
West Virginia (3)
Wisconsin (34)
249,557 Results for "dupont industrial biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Alpenglow Biosciences Expands Advisory Board with Two Esteemed Industry Leaders
April 3, 2025
·
3 min read
MaaT Pharma Announces Initiation of Coverage of its Stock by Gilbert Dupont/ Groupe Société Générale
MaaT Pharma, a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM dedicated to enhancing survival of patients with cancer, announces the initiation of coverage of its stock by Gilbert Dupont.
April 5, 2024
·
2 min read
FDA
FDA Moves to Restrict Industry Influence on Advisory Committees
Industry representatives will still be allowed at these meetings, but they will no longer have a spot on the advisory committee.
April 18, 2025
·
2 min read
·
Tristan Manalac
Business
DuPont Announces Regular Quarterly Dividend on Common Stock - October 17, 2023
DuPont announced that its Board of Directors has declared a third quarter dividend of thirty-six cents per share on the outstanding Common Stock of the Company payable on December 15, 2023, to holders of record of said stock at the close of business on November 30, 2023.
October 17, 2023
·
1 min read
Government
HHS Secretary Kennedy Accuses FDA Employees of Being Industry ‘Sock Puppet’
Leerink analysts warned that Kennedy’s remarks to FDA staff would likely be a negative for the biotech industry.
April 14, 2025
·
2 min read
·
Tristan Manalac
In partnership with GenScript
Beyond the Breakthrough: Industry Leaders Address Key Hurdles Facing Cell and Gene Therapies
At the GenScript Biotech Global Forum 2025, industry leaders celebrated CAR T cell therapy achievements while discussing ongoing challenges in manufacturing, distribution, treatment center capacity, and global payment structures for cell and gene therapies.
April 14, 2025
·
6 min read
·
BioSpace Insights
Policy
Trump’s Whiplash Tariffs and HHS Layoffs Set Biopharma Industry Ablaze
As the biopharma industry grapples with the uncertain macro environment brought on by the new administration, CEOs, regulators and many others speak out.
April 11, 2025
·
3 min read
·
BioSpace Editorial Staff
FDA
Banning Industry From FDA Adcomms Won’t ‘Move the Needle Much’ in Makary, RFK’s Fight Against COIs
FDA Commissioner Marty Makary last week announced a directive that would limit industry participation in the agency’s advisory committees. But not only do company reps serve only as non-voting members, a 1997 law actually requires industry involvement.
April 21, 2025
·
5 min read
·
Heather McKenzie
Drug Development
Diversity at the Forefront: Life Sciences Industry Champions Inclusive Representation
The industry remains unwavering in the commitment to increased clinical trial accessibility and representation.
February 25, 2025
·
1 min read
·
Lori Ellis
Press Releases
Bioscience Association Manitoba’s President Joins Manitoba Government U.S. Trade Council to Advocate for Manitoba’s Top Export Industry
January 24, 2025
·
1 min read
1 of 24,956
Next
